首页> 外文OA文献 >Post-marketing assessment of the safety of strontium ranelate; a novel case-only approach to the early detection of adverse drug reactions
【2h】

Post-marketing assessment of the safety of strontium ranelate; a novel case-only approach to the early detection of adverse drug reactions

机译:雷纳酸锶安全性的上市后评估;早期发现药物不良反应的新颖的仅案例方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECTRandomized controlled trials are the gold standard of drug efficacy assessment, but have limited power to assess adverse drug reactions.Observational data derived from larger populations of patients are often affected by confounding variables, many of which are difficult to measure or simply not known.
机译:随机对照试验是药物疗效评估的黄金标准,但评估不良药物反应的能力有限。来自大量患者的观察数据通常受混杂变量影响,其中许多难以衡量或根本不知道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号